Cardio-TriTest v6.5
510(k)K182790CardiovascularDPS
Cardio-Phoenix Inc. is listed for Cardio-TriTest v6.5 (K182790). The FDA list gives December 14, 2018 as the date of the final decision. The lead panel is Cardiovascular, and the database link on the FDA list is the 510(k) pathway. The primary product code on the FDA list is DPS. openFDA did not return a classification record for that code in this copy of the data. openFDA records this submission’s decision description as “Substantially Equivalent.” This paragraph is assembled only from those public fields. It is not an FDA review, not a determination of safety or effectiveness, and not medical advice. Official record: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K182790
- Date of final decision
- December 14, 2018
- Company on the FDA list
- Cardio-Phoenix Inc.
- Lead panel
- Cardiovascular
- Primary product code
- DPS
- openFDA device name for the code
- Electrocardiograph
- Device class
- 2
- Regulation number
- 870.2340
- openFDA decision description
- Substantially Equivalent
- openFDA decision code
- SESE
- Statement or summary label
- Summary